Moreover, reduction in NF-κB p65 protein in response to APO10LA supplementation was significantly correlated with decreased liver tumor volume and IL-6 protein expression [224], suggesting lycopene metabolites may exhibit protective effects against obesity associated hepatic inflammation and associated tumorigenesis. The gene discussed is NFKB1; the disease is Obesity.